| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 169.76B | 163.27B | 150.36B | 132.43B | 112.07B | 100.64B |
| Gross Profit | 58.45B | 55.18B | 43.84B | 34.98B | 28.51B | 26.33B |
| EBITDA | 36.02B | 33.05B | 24.55B | 17.04B | 12.18B | 10.79B |
| Net Income | 25.12B | 24.15B | 17.31B | 11.73B | 9.21B | 7.07B |
Balance Sheet | ||||||
| Total Assets | 190.39B | 194.40B | 182.70B | 164.85B | 130.51B | 115.01B |
| Cash, Cash Equivalents and Short-Term Investments | 20.57B | 16.75B | 17.64B | 15.56B | 20.20B | 12.80B |
| Total Debt | 28.15B | 22.73B | 36.67B | 33.25B | 15.87B | 16.05B |
| Total Liabilities | 71.01B | 73.20B | 80.55B | 78.48B | 54.50B | 47.65B |
| Stockholders Equity | 119.38B | 120.95B | 101.93B | 86.17B | 75.84B | 67.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.54B | 20.50B | -21.18B | 8.29B | -5.55B |
| Operating Cash Flow | 0.00 | 28.80B | 21.69B | -19.98B | 10.79B | -4.58B |
| Investing Cash Flow | 0.00 | -2.13B | -1.42B | -1.31B | -1.52B | -1.26B |
| Financing Cash Flow | 0.00 | -20.82B | -641.00M | 14.71B | -2.59B | 4.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥124.42B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥845.32B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
72 Outperform | ¥72.65B | 11.99 | 16.37% | 2.79% | 31.48% | 16.11% | |
69 Neutral | ¥216.19B | 10.37 | 9.02% | 3.11% | 1.25% | -3.97% | |
68 Neutral | ¥619.04B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
66 Neutral | ¥161.96B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |